Related Experiment Video

Updated: May 8, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Reperfusion strategies in ST-segment elevation myocardial infarction

T Stiermaier1, S Desch, G Schuler

  • 1Unit of Cardiology Department of Internal Medicine, Heart Center University of Leipzig, Leipzig, Germany - ingoeitel@gmx.de.

Minerva Medica
|September 7, 2013
PubMed

Insights

ST-elevation myocardial infarction (STEMI) requires emergent reperfusion. Primary percutaneous coronary intervention (PCI) is superior to fibrinolysis when timely, but regional systems guide optimal STEMI treatment strategies.

Area of Science:

  • Cardiology
  • Emergency Medicine

Background:

  • ST-elevation myocardial infarction (STEMI) is a significant global health burden.
  • Timely reperfusion of the infarct-related artery is critical for myocardial salvage and improved outcomes.

Purpose of the Study:

  • To review evidence for STEMI reperfusion therapies.
  • To summarize current guidelines for STEMI management.

Main Methods:

  • Review of clinical studies and guidelines on reperfusion strategies for STEMI.
  • Comparison of primary percutaneous coronary intervention (PCI) versus fibrinolysis.

Main Results:

  • Primary PCI is superior to fibrinolysis if performed rapidly at experienced centers.
  • Delays in PCI due to patient transfer pose a challenge.
  • Structured regional STEMI care systems aid in strategy selection.

Conclusions:

  • Optimal STEMI management involves selecting the best reperfusion strategy based on available resources and time.
  • Regional systems are essential for timely restoration of coronary blood flow in STEMI patients.

More Related Videos

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...